Close Menu

NEW YORK – Health Canada recently approved tests for SARS-CoV-2, the virus that causes COVID-19, permitting their marketing and use in that country. Recent approvals include the Seegene Allplex 2019-nCoV and DiaSorin Molecular Simplexa COVID-19 Direct, both of which are real-time RT-PCR assays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.

The New York Times reports that developers in New York City are increasingly interested in life science spaces.

A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.